JANX

JANX

USD

Janux Therapeutics Inc. Common Stock

$27.010+0.240 (0.897%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$26.770

Máximo

$27.660

Mínimo

$26.330

Volume

1.16M

Fundamentos da empresa

Capitalização de mercado

1.6B

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.91M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $21.73Atual $27.010Máximo $71.71

Notícias relacionadas

Analyst Upgrades

Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47

Barclays analyst Etzer Darout initiates coverage on Janux Therapeutics with a Overweight rating and announces Price Target of $47.

Ver mais
Barclays Initiates Coverage On Janux Therapeutics with Overweight Rating, Announces Price Target of $47
Analyst Upgrades

Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100

Truist Securities analyst Asthika Goonewardene initiates coverage on Janux Therapeutics with a Buy rating and announces Price Target of $100.

Ver mais
Truist Securities Initiates Coverage On Janux Therapeutics with Buy Rating, Announces Price Target of $100
Analyst Upgrades

Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target

Stifel analyst Bradley Canino reinstates Janux Therapeutics with a Buy and announces $45 price target.

Ver mais
Stifel Reinstates Buy on Janux Therapeutics, Announces $45 Price Target